JP Patent

JP5996633B2 — 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Assigned to Daicel Corp · Expires 2016-09-21 · 10y expired

What this patent protects

Patent listed against Topamax.

Drugs covered by this patent

Patent Metadata

Patent number
JP5996633B2
Jurisdiction
JP
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Daicel Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.